US Patent 11338041 Exon skipping oligomer conjugates for muscular dystrophy

Patent 11338041 was granted and assigned to Sarepta Therapeutics on May, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Sarepta Therapeutics

Current Assignee

Sarepta Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113380410

Patent Inventor Names

Marco A. Passini0

Frederick Joseph Schnell0

Gunnar J. Hanson0

Date of Patent

May 24, 2022

Patent Application Number

169382780

Date Filed

July 24, 2020

Patent Citations

‌

US Patent 10758629 Exon skipping oligomer conjugates for muscular dystrophy

‌

US Patent 11000600 Exon skipping oligomer conjugates for muscular dystrophy

Patent Primary Examiner

‌

Kimberly Chong

Antisense oligomer conjugates complementary to a selected target site in the human dystrophin gene to induce exon 52 skipping are described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11338041 Exon skipping oligomer conjugates for muscular dystrophy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API